In vitro stimulation by prostate extracts of rat ventral prostate stromal and epithelial cell division.

Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48

Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05

Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA (1997) 2.77

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60

Selective retention of dihydrotestosterone by prostatic nuclei. Nature (1968) 2.60

Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52

The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med (1988) 2.30

Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA (1992) 2.22

Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol (1991) 2.19

Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1991) 1.91

Receptor proteins for androgens. On the role of specific proteins in selective retention of 17-beta-hydroxy-5-alpha-androstan-3-one by rat ventral prostate in vivo and in vitro. J Biol Chem (1969) 1.74

How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet (1999) 1.68

Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med (1986) 1.63

Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst (1990) 1.60

Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol (1992) 1.46

Water-clear cell adenoma of the parathyroid. A case report with immunohistochemistry and electron microscopy. Arch Pathol Lab Med (1995) 1.43

A national survey of practice patterns in the noninvasive diagnosis of deep venous thrombosis. J Vasc Surg (1999) 1.39

Heart rate adjustment of exercise-induced ST segment depression. Improved risk stratification in the Framingham Offspring Study. Circulation (1991) 1.39

Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature (1992) 1.37

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes (1992) 1.36

Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol (1994) 1.36

Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol (2000) 1.34

Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience). Am J Cardiol (1991) 1.32

Letter: Levulinic esters. An alcohol protecting group applicable to some nucleosides. J Am Chem Soc (1975) 1.31

Risk of coronary heart disease in subjects with chest discomfort: the Framingham Heart Study. Am J Med (1990) 1.29

Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol (1992) 1.28

BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res (1999) 1.28

Identification and characterization of cvHsp. A novel human small stress protein selectively expressed in cardiovascular and insulin-sensitive tissues. J Biol Chem (1999) 1.26

Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J (1990) 1.24

Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med (1991) 1.22

A new method for indexing left ventricular mass for differences in body size. Am J Cardiol (1994) 1.21

Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 1.21

Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study. JAMA (1989) 1.17

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol (1992) 1.13

Is there a relationship between exercise systolic blood pressure response and left ventricular mass? The Framingham Heart Study. Ann Intern Med (1992) 1.10

Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci U S A (1991) 1.08

Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis (1986) 1.06

Anti-human RP105 sera induces lymphocyte proliferation. J Leukoc Biol (1999) 1.02

Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res (1990) 1.00

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators. Am J Cardiol (1996) 0.97

Lipids, glucose intolerance and vascular disease: the Framingham Study. Monogr Atheroscler (1985) 0.97

Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Circulation (2000) 0.93

Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg (1999) 0.92

In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Circulation (1999) 0.92

Studies on actin-azomercurial complexes. Biochemistry (1965) 0.91

New models for predicting cardiovascular events. J Clin Epidemiol (1994) 0.91

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Circulation (1998) 0.91

Constraint-induced therapy for moderate chronic upper extremity impairment after stroke. Brain Inj (2005) 0.91

Cochlear action potentials in experimentally induced hypothyroidism in guinea pigs. Acta Otolaryngol Suppl (1975) 0.91

Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4. Cancer Res (1989) 0.91

Deep venous thrombosis after percutaneous insertion of vena caval filters. J Vasc Surg (1999) 0.90

Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90

Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications. J Am Coll Cardiol (1997) 0.90

Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group. Biometrics (1994) 0.90

Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study. Cancer (1992) 0.90

Prevalence of intraventricular block in the general population: the Framingham Study. Am Heart J (1989) 0.89

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators. Am J Cardiol (1997) 0.89

Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum (1970) 0.89

Rat ventral prostate chromatin. Effect of androgens on its chemical composition, physical properties, and template activity. Biochemistry (1973) 0.88

Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity. Arch Biochem Biophys (1995) 0.88

Successful streptokinase therapy for catheter-induced subclavian vein thrombosis. Arch Intern Med (1980) 0.87

Prognostic use of a QRS scoring system after hospital discharge for initial acute myocardial infarction in the Framingham cohort. Am J Cardiol (1990) 0.87

A genetic analysis of the Werner syndrome region on human chromosome 8p. Genomics (1993) 0.87

H-gene-mediated resistance to Hessian fly exhibits features of penetration resistance to fungi. Phytopathology (2010) 0.87

Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87

Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86

Is alcohol consumption related to breast cancer? Results from the Framingham Heart Study. J Natl Cancer Inst (1989) 0.86

In situ synthesis of oligonucleotide arrays by using surface tension. J Am Chem Soc (2001) 0.86

Molecular characterization of a human scavenger receptor, human MARCO. Eur J Biochem (2000) 0.86

Tuberculosis screening in Washington state male correctional facilities. Chest (1986) 0.83

Solubilized DNA-dependent nuclear RNA polymerases from the mammary glands of late-pregnant rats. Biochim Biophys Acta (1975) 0.83

Solitary renal calix. JAMA (1978) 0.83

Mood and clinical status in patients with multiple myeloma. J Clin Oncol (1991) 0.83

Alterations in DMBA-induced rat mammary tumors by actinomycin D. J Natl Cancer Inst (1973) 0.83

A reproductive fitness cost associated with Hessian fly (Diptera: Cecidomyiidae) virulence to wheat's H gene-mediated resistance. J Econ Entomol (2011) 0.83

Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study. Cancer Treat Rep (1983) 0.82

Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. Am J Cardiol (1997) 0.82

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82

Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring. Am J Cardiol (1987) 0.82

Echocardiographic left ventricular hypertrophy: clinical characteristics. The Framingham Heart Study. Clin Exp Hypertens A (1992) 0.82

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation (1996) 0.82

The anti-GPIIb-IIIa agents: fundamental and clinical aspects. Haemostasis (1996) 0.82

Malacoplakia of the prostate. South Med J (1977) 0.81

The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81

Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography. Radiology (1985) 0.81

An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res (1987) 0.81

Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature. J Surg Oncol (1997) 0.81

Changes in template activity of rat ventral prostate chromatin after brief or prolonged in vivo exposure to androgen: evidence for a succession of chromatin "conformers". Biochem Biophys Res Commun (1973) 0.80

Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis. J Pharmacol Exp Ther (2000) 0.80

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. Circulation (1998) 0.80

The effects of cocaine injections on mouse thymocyte population. Proc Soc Exp Biol Med (1997) 0.80

Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80

Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI. Diabet Med (2007) 0.80

Conducting systematic reviews of intervention questions I: Writing the review protocol, formulating the question and searching the literature. Zoonoses Public Health (2014) 0.79